Found: 1

Select item for more details and to access through your institution.

  • Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico.

    Published in:
    NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00662-6
    By:
    • Ponce-de-León, Samuel;
    • Torres, Martha;
    • Soto-Ramírez, Luis Enrique;
    • Calva, Juan José;
    • Santillán-Doherty, Patricio;
    • Carranza-Salazar, Dora Eugenia;
    • Carreño, Juan Manuel;
    • Carranza, Claudia;
    • Juárez, Esmeralda;
    • Carreto-Binaghi, Laura E.;
    • Ramírez-Martínez, Luis;
    • Paz De la Rosa, Georgina;
    • Vigueras-Moreno, Rosalía;
    • Ortiz-Stern, Alejandro;
    • López-Vidal, Yolanda;
    • Macías, Alejandro E.;
    • Torres-Flores, Jesús;
    • Rojas-Martínez, Oscar;
    • Suárez-Martínez, Alejandro;
    • Peralta-Sánchez, Gustavo
    Publication type:
    Article